279 related articles for article (PubMed ID: 34838620)
21. Docetaxel/dimethyl-β-cyclodextrin inclusion complexes: preparation,
Giri BR; Lee J; Lim DY; Kim DW
Drug Dev Ind Pharm; 2021 Feb; 47(2):319-328. PubMed ID: 33576707
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
Patel SG; Rajput SJ
AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
[TBL] [Abstract][Full Text] [Related]
23. Improving the solubility and bioavailability of dihydroartemisinin by solid dispersions and inclusion complexes.
Ansari MT; Batty KT; Iqbal I; Sunderland VB
Arch Pharm Res; 2011 May; 34(5):757-65. PubMed ID: 21656361
[TBL] [Abstract][Full Text] [Related]
24. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Pralhad T; Rajendrakumar K
J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
[TBL] [Abstract][Full Text] [Related]
25. Preparation and Properties of Cyclodextrin Inclusion Complexes of
Zhang X; Su J; Wang X; Wang X; Liu R; Fu X; Li Y; Xue J; Li X; Zhang R; Chu X
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566111
[TBL] [Abstract][Full Text] [Related]
26. Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin.
Babu RJ; Pandit JK
Int J Pharm; 2004 Mar; 271(1-2):155-65. PubMed ID: 15129982
[TBL] [Abstract][Full Text] [Related]
27. Enhanced antibacterial activity of levofloxacin/hydroxypropyl-β-cyclodextrin inclusion complex: In vitro and in vivo evaluation.
Li Y; Zhou J; Gu J; Shao Q; Chen Y
Colloids Surf B Biointerfaces; 2022 Jul; 215():112514. PubMed ID: 35490541
[TBL] [Abstract][Full Text] [Related]
28. Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine.
Awais S; Farooq N; Muhammad SA; El-Serehy HA; Ishtiaq F; Afridi M; Ahsan H; Ullah A; Nadeem T; Sultana K
Molecules; 2023 May; 28(9):. PubMed ID: 37175270
[TBL] [Abstract][Full Text] [Related]
29. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R
Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923
[TBL] [Abstract][Full Text] [Related]
30. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
[TBL] [Abstract][Full Text] [Related]
31. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
Mura P; Faucci MT; Bettinetti GP
Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
[TBL] [Abstract][Full Text] [Related]
32. Binary inclusion complexes of diflunisal with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: Preparation and characterization.
Bashir M; Syed HK; Asghar S; Irfan M; Aslam N; Iqbal MS; Khan IU; Shah PA; Khan NR; Ahmad J; Saleem M; Asif M
Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2307-2315. PubMed ID: 33832905
[TBL] [Abstract][Full Text] [Related]
33. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
34. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
[TBL] [Abstract][Full Text] [Related]
35. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies.
Phillip Lee YH; Sathigari S; Jean Lin YJ; Ravis WR; Chadha G; Parsons DL; Rangari VK; Wright N; Babu RJ
Drug Dev Ind Pharm; 2009 Sep; 35(9):1113-20. PubMed ID: 19640249
[TBL] [Abstract][Full Text] [Related]
36. Preparation and
Al-Heibshy FNS; Başaran E; Öztürk N; Demirel M
Drug Dev Ind Pharm; 2020 Sep; 46(9):1495-1506. PubMed ID: 32804005
[TBL] [Abstract][Full Text] [Related]
37. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS
Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
[TBL] [Abstract][Full Text] [Related]
38. Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.
Hippalgaonkar K; Gul W; ElSohly MA; Repka MA; Majumdar S
AAPS PharmSciTech; 2011 Jun; 12(2):723-31. PubMed ID: 21637944
[TBL] [Abstract][Full Text] [Related]
39. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.
Ribeiro A; Figueiras A; Santos D; Veiga F
AAPS PharmSciTech; 2008; 9(4):1102-9. PubMed ID: 18975116
[TBL] [Abstract][Full Text] [Related]
40. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
Sherje A; Londhe V
Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
